Protein and energy requirements in healthy and ill paediatric patients

J L Bresson1

  • 1Hôpital des Enfants Malades, Paris, France.

Insights

Infant protein needs may be lower than thought, impacting malnutrition treatment. New estimates suggest lower safe protein intake levels for young children, influencing optimal nutrition strategies.

Area of Science:

  • Pediatrics
  • Nutritional Science
  • Biochemistry

Background:

  • Traditional estimates of infant energy and protein requirements may be overestimated.
  • Malnutrition is often attributed solely to reduced food intake, but metabolic factors are increasingly recognized.
  • Understanding protein metabolism is crucial for pediatric nutrition and managing malnutrition.

Purpose of the Study:

  • To re-evaluate and provide updated estimates for infant energy and protein requirements.
  • To explore the role of metabolic dysregulation, particularly protein breakdown, in childhood malnutrition.
  • To inform the management of malnourished children by defining an optimal protein:energy ratio.

Main Methods:

  • Reappraisal of existing data on infant nutritional needs.
  • Inclusion of findings from new scientific studies.
  • Analysis of protein metabolism, including synthesis and breakdown rates.

Main Results:

  • Available data suggest significantly lower energy and protein requirements for normal infants than previously estimated.
  • Safe protein intake levels proposed: 10 g/day for the first 2 years, and 12 g/day for the third year.
  • Increased protein breakdown, influenced by cytokines during inflammatory processes, can contribute to severe protein malnutrition.

Conclusions:

  • Revised estimates for infant protein requirements have direct implications for clinical practice and nutritional guidelines.
  • Metabolic dysregulation, specifically increased protein breakdown, is a significant factor in childhood malnutrition, alongside reduced food intake.
  • Nutritional support alone may not be sufficient for severe protein malnutrition caused by inflammatory processes.

Related Concept Videos

Proteins: Dietary Sources and Requirements01:28

Proteins: Dietary Sources and Requirements

Consuming animal-based products offers high-quality proteins that contain optimal levels and combinations of essential amino acids, crucial for tissue repair and growth. Foods like eggs, milk, fish, and most meats are a source of complete proteins. Legumes and cereals are abundant in proteins; however, they typically lack a full range of essential amino acids. As a result, they are considered incomplete protein sources. Some plant sources like soybeans, quinoa, and amaranth do contain complete...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...